Blueshift Asset Management, LLC Allogene Therapeutics, Inc. Transaction History

Blueshift Asset Management, LLC

  • $392 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$6.78 - $12.28 $100,418 - $181,879
-14,811 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$7.65 - $15.29 $113,304 - $226,460
14,811 New
14,811 $135,000
Q2 2021

Aug 13, 2021
SELL
$23.49 - $35.8 $282,443 - $430,459
-12,024 Closed
0 $0
Q1 2021

May 06, 2021
BUY
$25.79 - $39.02 $310,098 - $469,176
12,024 New
12,024 $424,000

Others Institutions Holding ALLO

# of Institutions
164
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $259M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email